Pay in 4 interest-free payments of $5.18 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
The weighted-average assumptions used to value employee and non-employee stock option awards granted during the years ended December 31, 2025 and 2024, using the Black-Scholes option pricing model, were as follows: The weighted-average assumptions used to value employee stock purchase plan shares granted during the year ended December 31, 2025, using the Black-Scholes option pricing model, were as follows: F-27 Stock-based Compensation Expense Stock-based compensation expense for restricted stock awards, stock options, and ESPP recognized in the Companys statements of operations and comprehensive loss is presented as follows (in thousands): As of December 31, 2025, total unrecognized stock-based compensation expense related to unvested restricted stock awards, stock options, and ESPP was $ 11
if you need a starting point, you might explore analyses available through Spinboss to see how evaluators weigh usability, value, and responsible play features across different sites
Due to their remarkable ability to regulate metabolism, they have been widely adopted in the management of type 2 diabetes mellitus (T2DM) and obesity
Related Articles GHK-Cu, KPV, BPC-157 & TB500 Blend: A Complete Guide | Preferred Regen ATL Peptide Therapy Injections | Preferred Regen ATL Peptide BPC-157 for Healing: Is It Worth the Risk
PMID: 41723572 Adv Sci (Weinh) MCU Upregulation Overactivates Mitophagy by Promoting VDAC1 Dimerization and Ubiquitination in the Hepatotoxicity of Cadmium
Charge Plug: JST-XHR-5P
US$ 21.72
US$ 20.00
US$ 27.49
US$ 26.12
US$ 23.73
US$ 28.37
US$ 22.60
